| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/29/2004 | US20040081990 Method for the identification of essential genes and therapeutic targets |
| 04/29/2004 | US20040081987 Methods and arrays for detecting biomolecules |
| 04/29/2004 | US20040081984 Ocular tear growth factor-like protein |
| 04/29/2004 | US20040081982 Neocentromere-based mini-chromosomes or artificial chromosomes |
| 04/29/2004 | US20040081978 Random-primed reverse transcriptase-in vitro transcription method for rna amplification |
| 04/29/2004 | US20040081976 Genomic screen for epigenetically silenced tumor suppressor genes |
| 04/29/2004 | US20040081974 Method and equipment to monitor nucleic acid hybridization on a dna chip using four-dimensional parameters |
| 04/29/2004 | US20040081971 Gastrointestinal disorders; cardiovascular disorders; autoimmune diseases; cell proliferation; antiinflammatory agents |
| 04/29/2004 | US20040081966 Chemical array linking layers |
| 04/29/2004 | US20040081962 Nucleic acids amplification |
| 04/29/2004 | US20040081958 Identification and use of molecular markers indicating cellular reprogramming |
| 04/29/2004 | US20040081687 Cholesterol group is linked to the optional linker group via a carbamoyl linkage and then linked to carbohydrate |
| 04/29/2004 | US20040081651 Crystal structure of the complex between one such antibody and the alpha 1-I domain of VLA-1, and to the use of this structural information for computational drug design |
| 04/29/2004 | US20040081648 Adzymes and uses thereof |
| 04/29/2004 | US20040081647 For inhibiting receptor-mediated signaling activity of an extracellular substrate polypeptide |
| 04/29/2004 | US20040081645 Glycogen storage disease type II treatment comprising human acid glucosidase, mannitol and sucrose in aqueous solution |
| 04/29/2004 | US20040081644 Amino acid sequences of human phosphatase peptides and proteins that are related to the protein tyrosine phosphatase subfamily |
| 04/29/2004 | US20040081638 Delivery of disease control in aquaculture and agriculture using nutritional feeds containing bioactive proteins produced by viruses |
| 04/29/2004 | US20040081637 Insertion target ligands into proteins; detection fluorescent signals; determination, calibration; gene therapy; antitumor agents |
| 04/29/2004 | US20040081636 Genetic engineering; polynucleotides |
| 04/29/2004 | US20040080750 Fluorescence correlation spectroscopy instrument and method of using the same |
| 04/29/2004 | DE10294485T5 Mit Mnk-Kinase homologe Proteine, die in die Regulation der Energiehomöostase und den Organellenmetabolismus involviert sind Mnk homologous proteins with kinase, that are involved in the regulation of energy homeostasis and the metabolism organelle |
| 04/29/2004 | DE10248301A1 Herstellung eines Lebend-Impfstoffes gegen Influenza-Viren Preparation of a live vaccine against influenza viruses |
| 04/29/2004 | CA2836656A1 Disease detection by digital protein truncation assays |
| 04/29/2004 | CA2649821A1 Polynucleotide sequences encoding .delta.bcl-2 for preventing and treating autoimmune diseases |
| 04/29/2004 | CA2515650A1 New adenoviruses, nucleic acids coding therefor and their use |
| 04/29/2004 | CA2503307A1 Soluble rna polymerase protein and methods for the use thereof |
| 04/29/2004 | CA2502902A1 Method of producing recombinant proteins in the mammary gland of non-transgenic mammals |
| 04/29/2004 | CA2502863A1 Expressional enhancers from viruses |
| 04/29/2004 | CA2502664A1 Sirna mediated gene silencing in transgenic animals |
| 04/29/2004 | CA2502649A1 Double-stranded rna structures and constructs, and methods for generating and using the same |
| 04/29/2004 | CA2502434A1 Plant alpha farnesene synthase and polynucleotides encoding same |
| 04/29/2004 | CA2502431A1 Method for the manufacture of nucleic acid molecules |
| 04/29/2004 | CA2502324A1 Glucagon - like peptide - 2 variants |
| 04/29/2004 | CA2502316A1 Antagonists il-15 |
| 04/29/2004 | CA2502312A1 Transplantable cell with immune modulator |
| 04/29/2004 | CA2502257A1 A method of modulating endothelial cell activity by modulating the functional levels level of sphingosine kinase |
| 04/29/2004 | CA2502250A1 Methods using gene trapped stem cells for marking pathways of stem cell differentiation and making and isolating differentiated cells |
| 04/29/2004 | CA2502243A1 A structured peptide scaffold for displaying turn libraries on phage |
| 04/29/2004 | CA2502201A1 Protein synthesis system using xenopus oocyte extract |
| 04/29/2004 | CA2502152A1 E.coli host cells with modified phos/psts periplasmic phosphate-binding proteins, and method of manufacturing recombinant fabs |
| 04/29/2004 | CA2502029A1 Site specific incorporation of keto amino acids into proteins |
| 04/29/2004 | CA2501994A1 Use of poly-alpha2,8-sialic acid mimetic peptides to modulate ncam functions |
| 04/29/2004 | CA2501340A1 Method for producing a mammal provided with resistance to an alpha-herpes virus mediated infection and mammal obtained by implementing said method and said mammal's progeny |
| 04/29/2004 | CA2501333A1 Factor involved in metastasis and uses thereof |
| 04/29/2004 | CA2500336A1 Improved immunotherapy |
| 04/29/2004 | CA2497313A1 Biomolecule transfer method using virus envelope and composition and system therefor |
| 04/29/2004 | CA2484760A1 Increasing host plant susceptibility to acrobacterium infection by overexpression of the arabidopsis vip1 gene |
| 04/29/2004 | CA2468273A1 Disease detection by digital protein truncation assays |
| 04/28/2004 | EP1413628A1 Method of determining dna base sequence |
| 04/28/2004 | EP1413626A1 Genes and proteins for the biosynthesis of the glycopeptide antibiotic A40926 |
| 04/28/2004 | EP1413587A2 Modified complement system regulator |
| 04/28/2004 | EP1413586A1 Regulation of the Cre recombinase using a dissociation/re-association system of said recombinase |
| 04/28/2004 | EP1413585A2 Novel, recombinantly produced spider silk analogs |
| 04/28/2004 | EP1413353A1 Chemical array linking layers |
| 04/28/2004 | EP1413352A1 Linking to chemical array assemblies with metal layers |
| 04/28/2004 | EP1413314A1 Medicinal compositions |
| 04/28/2004 | EP1412758A2 Protein arrays, methods for their preparation and methods for the detection of intermolecular interactions |
| 04/28/2004 | EP1412757A2 Method for identification of proteins from intracellular bacteria |
| 04/28/2004 | EP1412753A2 Biochip and the production method thereof |
| 04/28/2004 | EP1412752A1 Methods and compositions for determining the purity of and purifying chemically synthesized nucleic acids |
| 04/28/2004 | EP1412750A2 T1r hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds |
| 04/28/2004 | EP1412748A2 Mage-a3 peptides presented by hla class ii molecules |
| 04/28/2004 | EP1412538A2 Methods for the simultaneous detection of hcv antigens and hcv antibodies |
| 04/28/2004 | EP1412537A2 Cardiotoxin molecular toxicology modeling |
| 04/28/2004 | EP1412535A2 Microarrays for cell phenotyping and manipulation |
| 04/28/2004 | EP1412534A2 Method for determining the capacity of fusarium in producing trichothecene toxins |
| 04/28/2004 | EP1412532A2 Method to detect splice variants of the calcineurin gene |
| 04/28/2004 | EP1412531A2 Il-4 receptor sequence variation associated with type 1 diabetes |
| 04/28/2004 | EP1412530A2 Ratio-based oligonucleotide probe selection |
| 04/28/2004 | EP1412529A2 Methods for assessing the risk of obesity based on allelic variations in the 5'-flanking region of the insulin gene |
| 04/28/2004 | EP1412523A2 Methods of profiling gene expression, protein or metabolite levels |
| 04/28/2004 | EP1412522A1 Amplifiable probe |
| 04/28/2004 | EP1412521A2 Method for specific, fast detection of threadlike bacteria |
| 04/28/2004 | EP1412519A2 Configurable dynamic three dimensional array |
| 04/28/2004 | EP1412518A2 Sorting and immobilization system for nucleic acids using synthetic binding systems |
| 04/28/2004 | EP1412517A2 Methods, kits and compositions of combination oligomers |
| 04/28/2004 | EP1412515A2 Treatment of cns disorders using d-amino acid oxidase and d-aspartate oxidase antagonists |
| 04/28/2004 | EP1412513A2 Phosphate limited inducible promoter and a bacillus expression system |
| 04/28/2004 | EP1412512A4 Detection of ras mutations |
| 04/28/2004 | EP1412512A2 Detection of ras mutations |
| 04/28/2004 | EP1412510A2 Aav vector packaging plasmid for producing wtaav particles or pseudotyped aav particles without helper viruses, by means of a single transfection |
| 04/28/2004 | EP1412509A2 Rna amplification system using plant components in animal cells |
| 04/28/2004 | EP1412508A2 Molecular vector for the genophenotypic characterisation of v3 sequences of hiv-1 gp120 |
| 04/28/2004 | EP1412507A2 Transformation method for obtaining marker-free plants |
| 04/28/2004 | EP1412506A2 Regulation of peroxisomal fatty acid transport in plants |
| 04/28/2004 | EP1412505A2 Dna sequences for regulating transcription |
| 04/28/2004 | EP1412504A2 Methods of rna and protein synthesis |
| 04/28/2004 | EP1412503A2 A fusion protein |
| 04/28/2004 | EP1412502A2 Use of clya hemolysin for excretion of fusion proteins |
| 04/28/2004 | EP1412501A1 Hepatitis b virus pre-s1 derived synthetic polypeptides and uses thereof |
| 04/28/2004 | EP1412500A2 Nucleic acids coding for a isum2a polypeptide and use of said nucleic acids to obtain transformed plants producing seeds altered in germ development |
| 04/28/2004 | EP1412499A2 Cytokine polypeptides |
| 04/28/2004 | EP1412498A2 Polynucleotides expressed in dendritic cells and polypeptides encoded thereby |
| 04/28/2004 | EP1412497A2 Engineered biosynthesis of polyenes |
| 04/28/2004 | EP1412496A2 Reversed mammalian protein-protein interaction trap |
| 04/28/2004 | EP1412495A2 A method for producing recombined polynucleotides |
| 04/28/2004 | EP1412494A2 A molecular marker based on the frk2 (fructokinase 2) gene |
| 04/28/2004 | EP1412493A2 Methods and compositions relating to improved lentiviral vector production systems |
| 04/28/2004 | EP1412492A2 Regulator of calcineurin |